Brief: FIGHT DMD trial results selected for late-breaking presentation at MDA clinical & scientific conference
19/03/2025 20:20
March 19 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O: FIGHT DMD TRIAL RESULTS SELECTED FOR LATE-BREAKING PRESENTATION AT MDA CLINICAL & SCIENTIFIC CONFERENCE Source text: ID:nPn25KRFMa Further company coverage: CPIX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM